NCT04600323View on ClinicalTrials.gov

Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Metabolic AcidosisChronic Kidney DiseaseCognitive Dysfunction
Interventions
DRUG

Sodium Bicarbonate Tablets

Participants will be given sodium bicarbonate at 0.5 mEq/kg-LBW/day for 12 months

DRUG

Placebo

Participants will be given placebo at 0.5 mEq/kg-LBW/day for 12 months

Trial Locations (1)

80045

University of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT04600323 - Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD | Biotech Hunter | Biotech Hunter